Location: Madrid
Type: Permanent
Salary: Circa €200,000 + package (dependent on experience and location)

Overview

An innovative, clinically driven biotechnology organisation is seeking an Executive Medical Director with a background in Medical Oncology to support the advancement of a growing oncology pipeline.

The organisation is developing multiple small molecule assets across solid tumour indications, with several studies currently in Phase 1 and Phase 2, and select programmes progressing towards Phase 3. A scalable clinical platform has been established, enabling rapid expansion of the portfolio as new compounds enter development.

This is a highly visible role that combines strategic leadership with hands on clinical execution.

Key Responsibilities

• Provide medical leadership across early and mid stage clinical development programmes in oncology (Phase 1 and Phase 2, with progression into Phase 3)

• Lead the design and execution of clinical trials, including protocol development and study strategy

• Actively contribute to the clinical oversight of ongoing studies, including data review and patient level assessments

• Participate in and lead investigator meetings, advisory boards, and external scientific interactions

• Collaborate cross functionally with clinical operations, regulatory, translational sciences, and senior leadership

• Support the expansion of the clinical pipeline within a platform driven development model

• Ensure clinical programmes are aligned with evolving standards of care and clinical practice in oncology

• Represent the organisation externally with investigators, partners, and key opinion leaders

Candidate Profile

• MD qualified with specialisation in Oncology (essential)

• Minimum 4 to 5 years of experience within the pharmaceutical or biotechnology industry

• Strong experience in early phase clinical development, particularly Phase 1 and Phase 2 oncology trials

• Proven involvement in designing and delivering clinical studies

• Solid understanding of clinical practice and patient management in oncology

• Comfortable operating in a hands on capacity, including data review and study level involvement

• Experience working with small molecule programmes is highly desirable

• Ability to operate both strategically and operationally within a dynamic environment

Why Consider This Opportunity

• Opportunity to play a key role in shaping a growing oncology pipeline

• Exposure to a scalable clinical platform with multiple compounds entering development

• Balance of strategic influence and hands on clinical impact

• Collaborative, science led environment with strong growth potential